Correlation Between NYSE Composite and Enzon Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Enzon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Enzon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NYSE Composite and Enzon Pharmaceuticals, you can compare the effects of market volatilities on NYSE Composite and Enzon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Enzon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Enzon Pharmaceuticals.

Diversification Opportunities for NYSE Composite and Enzon Pharmaceuticals

0.0

Correlation Coefficient

NYSE Composite  Enzon Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between NYSE and Enzon is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Enzon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enzon Pharmaceuticals and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Enzon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enzon Pharmaceuticals has no effect on the direction of NYSE Composite i.e., NYSE Composite and Enzon Pharmaceuticals go up and down completely randomly.

Pair Corralation between NYSE Composite and Enzon Pharmaceuticals

If you would invest  1,920,711  in NYSE Composite on December 21, 2024 and sell it today you would earn a total of  33,016  from holding NYSE Composite or generate 1.72% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

NYSE Composite  vs.  Enzon Pharmaceuticals

Pair Trading with NYSE Composite and Enzon Pharmaceuticals

The main advantage of trading using opposite NYSE Composite and Enzon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Enzon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzon Pharmaceuticals will offset losses from the drop in Enzon Pharmaceuticals' long position.

The idea behind NYSE Composite and Enzon Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.